Skip to main content
Erschienen in: Cancer Causes & Control 6/2013

01.06.2013 | Original paper

Associations between urinary soy isoflavonoids and two inflammatory markers in adults in the United States in 2005–2008

verfasst von: Holly L. Nicastro, Alison M. Mondul, Sabine Rohrmann, Elizabeth A. Platz

Erschienen in: Cancer Causes & Control | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to determine the association between urinary isoflavonoid (genistein, daidzein, and the daidzein metabolites O-desmethylangolensin (O-DMA) and equol) excretion and markers of inflammation in adults in the United States in National Health and Nutrition Examination Survey (NHANES) 2005–2008.

Methods

The NHANES is a cross-sectional study conducted by the National Center for Health Statistics to study the health and nutritional status of people living in the United States. The analysis included 1,683 participants from study years 2005–2008 for whom urinary isoflavonoids were measured and who met inclusion criteria. Urinary isoflavonoids were measured by HPLC-APPI-MS/MS. Serum C-reactive protein (CRP) was measured by latex-based nephelometry. White blood cell (WBC) count was measured by Coulter counting. Multivariable linear regression was used to calculate the geometric mean values of the markers, and multivariable logistic regression was used to estimate the odds of high CRP (≥3 mg/L) and of high WBC count (≥7,900/μL) by quartile of urinary isoflavonoid (nmol/mg creatinine).

Results

The highest quartile of genistein (OR = 0.62; 95 % CI 0.39–0.99) was associated with significantly decreased odds of high CRP compared with the lowest quartile. The sum of daidzein and its metabolites was significantly inversely associated with serum CRP concentration (p-trend = 0.017). Equol was inversely associated with WBC count (p-trend < 0.0001). O-DMA was the only isoflavonoid whose excretion was significantly associated with a decrease in both CRP (p-trend = 0.024) and WBC count (p-trend < 0.0001).

Conclusions

Though no clear pattern emerged, higher excretion of certain soy isoflavonoids was associated with decreased CRP concentration and WBC counts, suggesting a possible inverse association between soy intake and inflammation.
Literatur
1.
Zurück zum Zitat Zuman P, Somer G (2000) Polarographic and voltammetric behavior of selenious acid and its use in analysis. Talanta 51:645–665PubMedCrossRef Zuman P, Somer G (2000) Polarographic and voltammetric behavior of selenious acid and its use in analysis. Talanta 51:645–665PubMedCrossRef
2.
Zurück zum Zitat Bingham SA (2000) Diet and colorectal cancer prevention. Biochem Soc Trans 28:12–16PubMed Bingham SA (2000) Diet and colorectal cancer prevention. Biochem Soc Trans 28:12–16PubMed
3.
Zurück zum Zitat Kim YS, Young MR, Bobe G, Colburn NH, Milner JA (2009) Bioactive food components, inflammatory targets, and cancer prevention. Cancer Prev Res (Phila) 2:200–208CrossRef Kim YS, Young MR, Bobe G, Colburn NH, Milner JA (2009) Bioactive food components, inflammatory targets, and cancer prevention. Cancer Prev Res (Phila) 2:200–208CrossRef
5.
Zurück zum Zitat Arber N, Levin B (2008) Chemoprevention of colorectal neoplasia: the potential for personalized medicine. Gastroenterology 134:1224–1237PubMedCrossRef Arber N, Levin B (2008) Chemoprevention of colorectal neoplasia: the potential for personalized medicine. Gastroenterology 134:1224–1237PubMedCrossRef
6.
Zurück zum Zitat Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94:252–266PubMedCrossRef Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94:252–266PubMedCrossRef
7.
Zurück zum Zitat Meyskens FL Jr, McLaren CE, Pelot D et al (2008) Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila) 1:32–38CrossRef Meyskens FL Jr, McLaren CE, Pelot D et al (2008) Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila) 1:32–38CrossRef
8.
Zurück zum Zitat Arber N, Spicak J, Racz I et al (2011) Five-year analysis of the prevention of colorectal sporadic adenomatous polyps trial. Am J Gastroenterol 106:1135–1146PubMedCrossRef Arber N, Spicak J, Racz I et al (2011) Five-year analysis of the prevention of colorectal sporadic adenomatous polyps trial. Am J Gastroenterol 106:1135–1146PubMedCrossRef
9.
Zurück zum Zitat Benamouzig R, Deyra J, Martin A et al (2003) Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 125:328–336PubMedCrossRef Benamouzig R, Deyra J, Martin A et al (2003) Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 125:328–336PubMedCrossRef
10.
Zurück zum Zitat Lowe GD (2005) Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 3:1618–1627PubMedCrossRef Lowe GD (2005) Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 3:1618–1627PubMedCrossRef
11.
Zurück zum Zitat Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA 291:585–590PubMedCrossRef Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA 291:585–590PubMedCrossRef
12.
Zurück zum Zitat Heikkila K, Ebrahim S, Rumley A, Lowe G, Lawlor DA (2007) Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British Women’s Heart and Health Study. Cancer Epidemiol Biomarkers Prev 16:1155–1159PubMedCrossRef Heikkila K, Ebrahim S, Rumley A, Lowe G, Lawlor DA (2007) Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British Women’s Heart and Health Study. Cancer Epidemiol Biomarkers Prev 16:1155–1159PubMedCrossRef
13.
Zurück zum Zitat Trichopoulos D, Psaltopoulou T, Orfanos P, Trichopoulou A, Boffetta P (2006) Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev 15:381–384PubMedCrossRef Trichopoulos D, Psaltopoulou T, Orfanos P, Trichopoulou A, Boffetta P (2006) Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev 15:381–384PubMedCrossRef
14.
Zurück zum Zitat Siemes C, Visser LE, Coebergh JW et al (2006) C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 24:5216–5222PubMedCrossRef Siemes C, Visser LE, Coebergh JW et al (2006) C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 24:5216–5222PubMedCrossRef
15.
Zurück zum Zitat Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805–1812PubMed Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805–1812PubMed
16.
Zurück zum Zitat Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA (2008) C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 123:1133–1140PubMedCrossRef Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA (2008) C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 123:1133–1140PubMedCrossRef
17.
Zurück zum Zitat Sprague BL, Trentham-Dietz A, Klein BE et al (2008) Physical activity, white blood cell count, and lung cancer risk in a prospective cohort study. Cancer Epidemiol Biomarkers Prev 17:2714–2722PubMedCrossRef Sprague BL, Trentham-Dietz A, Klein BE et al (2008) Physical activity, white blood cell count, and lung cancer risk in a prospective cohort study. Cancer Epidemiol Biomarkers Prev 17:2714–2722PubMedCrossRef
18.
Zurück zum Zitat Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA (2001) White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol 154:758–764PubMedCrossRef Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA (2001) White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol 154:758–764PubMedCrossRef
19.
Zurück zum Zitat Dong JY, Qin LQ (2011) Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 125:315–323PubMedCrossRef Dong JY, Qin LQ (2011) Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 125:315–323PubMedCrossRef
20.
Zurück zum Zitat Trock BJ, Hilakivi-Clarke L, Clarke R (2006) Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98:459–471PubMedCrossRef Trock BJ, Hilakivi-Clarke L, Clarke R (2006) Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98:459–471PubMedCrossRef
21.
Zurück zum Zitat Barnes S, Boersma B, Patel R et al (2000) Isoflavonoids and chronic disease: mechanisms of action. Biofactors 12:209–215PubMedCrossRef Barnes S, Boersma B, Patel R et al (2000) Isoflavonoids and chronic disease: mechanisms of action. Biofactors 12:209–215PubMedCrossRef
22.
Zurück zum Zitat Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S (1998) Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol 54:105–112PubMed Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S (1998) Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol 54:105–112PubMed
23.
Zurück zum Zitat Murphy PA, Barua K, Hauck CC (2002) Solvent extraction selection in the determination of isoflavones in soy foods. J Chromatogr B Analyt Technol Biomed Life Sci 777:129–138PubMedCrossRef Murphy PA, Barua K, Hauck CC (2002) Solvent extraction selection in the determination of isoflavones in soy foods. J Chromatogr B Analyt Technol Biomed Life Sci 777:129–138PubMedCrossRef
24.
Zurück zum Zitat Atkinson C, Frankenfeld CL, Lampe JW (2005) Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 230:155–170 Atkinson C, Frankenfeld CL, Lampe JW (2005) Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 230:155–170
25.
Zurück zum Zitat Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS, Salpeter EE (2006) Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 8:538–554PubMedCrossRef Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS, Salpeter EE (2006) Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 8:538–554PubMedCrossRef
26.
Zurück zum Zitat Hall WL, Vafeiadou K, Hallund J, et al. (2005) Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 82:1260–1268; quiz 1365–1266 Hall WL, Vafeiadou K, Hallund J, et al. (2005) Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 82:1260–1268; quiz 1365–1266
27.
Zurück zum Zitat Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA (2006) Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 83:1118–1125PubMed Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA (2006) Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 83:1118–1125PubMed
28.
Zurück zum Zitat Maskarinec G, Steude JS, Franke AA, Cooney RV (2009) Inflammatory markers in a 2-year soy intervention among premenopausal women. J Inflamm (Lond) 6:9 Maskarinec G, Steude JS, Franke AA, Cooney RV (2009) Inflammatory markers in a 2-year soy intervention among premenopausal women. J Inflamm (Lond) 6:9
29.
Zurück zum Zitat Nikander E, Metsa-Heikkila M, Tiitinen A, Ylikorkala O (2003) Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. J Clin Endocrinol Metab 88:5180–5185PubMedCrossRef Nikander E, Metsa-Heikkila M, Tiitinen A, Ylikorkala O (2003) Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. J Clin Endocrinol Metab 88:5180–5185PubMedCrossRef
30.
Zurück zum Zitat Riesco E, Choquette S, Audet M, Lebon J, Tessier D, Dionne IJ (2012) Effect of exercise training combined with phytoestrogens on adipokines and C-reactive protein in postmenopausal women: a randomized trial. Metabolism 61:273–280PubMedCrossRef Riesco E, Choquette S, Audet M, Lebon J, Tessier D, Dionne IJ (2012) Effect of exercise training combined with phytoestrogens on adipokines and C-reactive protein in postmenopausal women: a randomized trial. Metabolism 61:273–280PubMedCrossRef
31.
Zurück zum Zitat Jenkins DJ, Kendall CW, Connelly PW et al (2002) Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism 51:919–924PubMedCrossRef Jenkins DJ, Kendall CW, Connelly PW et al (2002) Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism 51:919–924PubMedCrossRef
32.
Zurück zum Zitat Blum A, Lang N, Peleg A et al (2003) Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia. Am Heart J 145:e7PubMedCrossRef Blum A, Lang N, Peleg A et al (2003) Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia. Am Heart J 145:e7PubMedCrossRef
33.
Zurück zum Zitat Hilpert KF, Kris-Etherton PM, West SG (2005) Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults. J Nutr 135:1075–1079PubMed Hilpert KF, Kris-Etherton PM, West SG (2005) Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults. J Nutr 135:1075–1079PubMed
34.
Zurück zum Zitat Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS (2008) Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women. Eur J Clin Nutr 62:1419–1425PubMedCrossRef Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS (2008) Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women. Eur J Clin Nutr 62:1419–1425PubMedCrossRef
35.
Zurück zum Zitat D’Anna R, Baviera G, Corrado F, Cancellieri F, Crisafulli A, Squadrito F (2005) The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. Acta Obstet Gynecol Scand 84:474–477PubMed D’Anna R, Baviera G, Corrado F, Cancellieri F, Crisafulli A, Squadrito F (2005) The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. Acta Obstet Gynecol Scand 84:474–477PubMed
36.
37.
Zurück zum Zitat Yoon SS, Dillon CF, Carroll M, Illoh K, Ostchega Y (2010) Effects of statins on serum inflammatory markers: the U.S. National Health and Nutrition Examination Survey 1999–2004. J Atheroscler Thromb 17:1176–1182PubMedCrossRef Yoon SS, Dillon CF, Carroll M, Illoh K, Ostchega Y (2010) Effects of statins on serum inflammatory markers: the U.S. National Health and Nutrition Examination Survey 1999–2004. J Atheroscler Thromb 17:1176–1182PubMedCrossRef
38.
Zurück zum Zitat Shaheen M, Echeverry D, Oblad MG, Montoya MI, Teklehaimanot S, Akhtar AJ (2007) Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III]. Diabetes Res Clin Pract 75:320–326PubMedCrossRef Shaheen M, Echeverry D, Oblad MG, Montoya MI, Teklehaimanot S, Akhtar AJ (2007) Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III]. Diabetes Res Clin Pract 75:320–326PubMedCrossRef
39.
Zurück zum Zitat Valentin-Blasini L, Blount BC, Caudill SP, Needham LL (2003) Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Expo Anal Environ Epidemiol 13:276–282PubMedCrossRef Valentin-Blasini L, Blount BC, Caudill SP, Needham LL (2003) Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Expo Anal Environ Epidemiol 13:276–282PubMedCrossRef
40.
Zurück zum Zitat Valentin-Blasini L, Sadowski MA, Walden D, Caltabiano L, Needham LL, Barr DB (2005) Urinary phytoestrogen concentrations in the U.S. population (1999–2000). J Expo Anal Environ Epidemiol 15:509–523PubMedCrossRef Valentin-Blasini L, Sadowski MA, Walden D, Caltabiano L, Needham LL, Barr DB (2005) Urinary phytoestrogen concentrations in the U.S. population (1999–2000). J Expo Anal Environ Epidemiol 15:509–523PubMedCrossRef
41.
Zurück zum Zitat Buckley DI, Fu RW, Freeman M, Rogers K, Helfand M (2009) C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the US preventive services task force. Ann Intern Med 151:483–495 Buckley DI, Fu RW, Freeman M, Rogers K, Helfand M (2009) C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the US preventive services task force. Ann Intern Med 151:483–495
42.
Zurück zum Zitat Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM (2005) C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med 142:425–432PubMed Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM (2005) C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med 142:425–432PubMed
43.
Zurück zum Zitat Shankar A, Wang JJ, Rochtchina E, Yu MC, Kefford R, Mitchell P (2006) Association between circulating white blood cell count and cancer mortality: a population-based cohort study. Arch Intern Med 166:188–194PubMedCrossRef Shankar A, Wang JJ, Rochtchina E, Yu MC, Kefford R, Mitchell P (2006) Association between circulating white blood cell count and cancer mortality: a population-based cohort study. Arch Intern Med 166:188–194PubMedCrossRef
44.
Zurück zum Zitat Kalkwarf HJ, Khoury JC, Lanphear BP (2003) Milk intake during childhood and adolescence, adult bone density, and osteoporotic fractures in US women. Am J Clin Nutr 77:257–265PubMed Kalkwarf HJ, Khoury JC, Lanphear BP (2003) Milk intake during childhood and adolescence, adult bone density, and osteoporotic fractures in US women. Am J Clin Nutr 77:257–265PubMed
45.
Zurück zum Zitat Wu SH, Shu XO, Chow WH et al (2012) Soy food intake and circulating levels of inflammatory markers in Chinese women. J Acad Nutr Diet 112(996–1004):e1004 Wu SH, Shu XO, Chow WH et al (2012) Soy food intake and circulating levels of inflammatory markers in Chinese women. J Acad Nutr Diet 112(996–1004):e1004
46.
Zurück zum Zitat Nanri A, Moore MA, Kono S (2007) Impact of C-reactive protein on disease risk and its relation to dietary factors. Asian Pac J Cancer Prev 8:167–177PubMed Nanri A, Moore MA, Kono S (2007) Impact of C-reactive protein on disease risk and its relation to dietary factors. Asian Pac J Cancer Prev 8:167–177PubMed
47.
Zurück zum Zitat Gunter MJ, Stolzenberg-Solomon R, Cross AJ et al (2006) A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 66:2483–2487PubMedCrossRef Gunter MJ, Stolzenberg-Solomon R, Cross AJ et al (2006) A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 66:2483–2487PubMedCrossRef
48.
Zurück zum Zitat Erlinger TP, Muntner P, Helzlsouer KJ (2004) WBC count and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey mortality study. Cancer Epidemiol Biomarkers Prev 13:1052–1056PubMed Erlinger TP, Muntner P, Helzlsouer KJ (2004) WBC count and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey mortality study. Cancer Epidemiol Biomarkers Prev 13:1052–1056PubMed
49.
Zurück zum Zitat Frankenfeld CL (2011) Dairy consumption is a significant correlate of urinary equol concentration in a representative sample of US adults. Am J Clin Nutr 93:1109–1116PubMedCrossRef Frankenfeld CL (2011) Dairy consumption is a significant correlate of urinary equol concentration in a representative sample of US adults. Am J Clin Nutr 93:1109–1116PubMedCrossRef
50.
Zurück zum Zitat Seow A, Shi CY, Franke AA, Hankin JH, Lee HP, Yu MC (1998) Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev 7:135–140PubMed Seow A, Shi CY, Franke AA, Hankin JH, Lee HP, Yu MC (1998) Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev 7:135–140PubMed
51.
Zurück zum Zitat Maskarinec G, Singh S, Meng L, Franke AA (1998) Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol Biomarkers Prev 7:613–619PubMed Maskarinec G, Singh S, Meng L, Franke AA (1998) Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol Biomarkers Prev 7:613–619PubMed
52.
Zurück zum Zitat Franke AA, Hebshi SM, Pagano I, Kono N, Mack WJ, Hodis HN (2010) Urine accurately reflects circulating isoflavonoids and ascertains compliance during soy intervention. Cancer Epidemiol Biomarkers Prev 19:1775–1783PubMedCrossRef Franke AA, Hebshi SM, Pagano I, Kono N, Mack WJ, Hodis HN (2010) Urine accurately reflects circulating isoflavonoids and ascertains compliance during soy intervention. Cancer Epidemiol Biomarkers Prev 19:1775–1783PubMedCrossRef
53.
Zurück zum Zitat Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC (2002) Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23:1491–1496PubMedCrossRef Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC (2002) Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23:1491–1496PubMedCrossRef
54.
Zurück zum Zitat Greendale GA, FitzGerald G, Huang MH et al (2002) Dietary soy isoflavones and bone mineral density: results from the study of women’s health across the nation. Am J Epidemiol 155:746–754PubMedCrossRef Greendale GA, FitzGerald G, Huang MH et al (2002) Dietary soy isoflavones and bone mineral density: results from the study of women’s health across the nation. Am J Epidemiol 155:746–754PubMedCrossRef
55.
Zurück zum Zitat Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A et al (2008) Ethnic differences in C-reactive protein concentrations. Clin Chem 54:1027–1037PubMedCrossRef Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A et al (2008) Ethnic differences in C-reactive protein concentrations. Clin Chem 54:1027–1037PubMedCrossRef
Metadaten
Titel
Associations between urinary soy isoflavonoids and two inflammatory markers in adults in the United States in 2005–2008
verfasst von
Holly L. Nicastro
Alison M. Mondul
Sabine Rohrmann
Elizabeth A. Platz
Publikationsdatum
01.06.2013
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 6/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0198-9

Weitere Artikel der Ausgabe 6/2013

Cancer Causes & Control 6/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.